Axcella Announces Patent Issuance for AXA™ Candidate AXA1125 Methods of Use  Business Wire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial …